US Patent Issued to Shanghai Renyousheng Gene Technology on Sept. 16 for "Recombinant human 2IG-B7-H3 protein coding gene, recombinant vector, host cell comprising the same, pharmaceutical composition and use thereof" (Chinese Inventor)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,846, issued on Sept. 16, was assigned to Shanghai Renyousheng Gene Technology Co. Ltd. (Shanghai).

"Recombinant human 2IG-B7-H3 protein coding gene, recombinant vector, host cell comprising the same, pharmaceutical composition and use thereof" was invented by Haidong Huang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the field of genetic engineering, in particular to a recombinant human 2Ig-B7-H3 protein encoding gene, a protein, a recombinant vector, and a pharmaceutical composition including the gene or protein. The recombinant human 2Ig-B7-H3 protein encoding gene comprises a nucleotide sequence shown...